Literature DB >> 32074016

What Keeps Patients Out of Clinical Trials?

Lori M Minasian1, Joseph M Unger2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32074016     DOI： 10.1200/JOP.19.00735

Source DB:  PubMed          Journal:  JCO Oncol Pract        ISSN： 2688-1527


× No keyword cloud information.
  4 in total

1.  Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer.

Authors:  Cristina Merkhofer; Shasank Chennupati; Qin Sun; Keith D Eaton; Renato G Martins; Scott D Ramsey; Bernardo H L Goulart
Journal:  JCO Oncol Pract       Date:  2021-08

Review 2.  Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations.

Authors:  Vincent Lemaire; Colby S Shemesh; Anand Rotte
Journal:  J Exp Clin Cancer Res       Date:  2021-10-01

3.  Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective.

Authors:  Keith T Flaherty; James H Doroshow; Susan Galbraith; Antoni Ribas; Paul G Kluetz; Richard Pazdur; Marc R Theoret
Journal:  Cancer Discov       Date:  2021-07-21       Impact factor: 39.397

4.  "When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.

Authors:  Joseph M Unger; Dawn L Hershman; Cathee Till; Lori M Minasian; Raymond U Osarogiagbon; Mark E Fleury; Riha Vaidya
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.